Linked Resources

Clinical Practice Guidelines

NASTAD PrEP/PEP Access Microsite: Long-Acting Injectable PrEP. 

Advocates’ Primer on Injectable Cabotegravir for PrEP: Trials, Approvals, Rollout And More

Last updated February 2022.

Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 update). A clinical practice guideline.

US Public Health Service. Centers for Disease Control and Prevention; 2021.

Guidance during disruption of STD clinical services. 

Centers for Disease Control and Prevention; March 2022.

Sexually transmitted infections treatment guidelines. 2021.

Centers for Disease Control and Prevention. Last reviewed July 2021.

2018 quick reference guide: recommended laboratory HIV testing algorithm for serum or plasma specimens. 

CDC Stacks. Centers for Disease Control and Prevention; last updated January 2018.

The Fenway Guide to Lesbian, Gay, Bisexual, and Transgender Health. 

Makadon H, et al, American College of Physicians (ACP), eds. 2nd ed. Boston, MA: Fenway Health; 2015.

Professional Organizations & Resources

American Academy of HIV Medicine.

Basic statistics. 

Centers for Disease Control and Prevention; updated June 2022. 

National Clinician Consultation Center.

University of California, San Francisco; 2020.

HIV drug interactions.

University of Liverpool (website); updated August 2022.

Related activities

Long-Acting Injectable PrEP

Bringing HIV Prevention to a New Level

Faculty: Ian Frank, MD & Colleen F. Kelley, MD, MPH
Release: 09/22/2022
Expiration: 09/22/2023